ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777 |
Resumo: | The Allergic Rhinitis and Its Impact on Asthma (ARIA) initiative started more than 20 years ago and has developed and disseminated evidence-based guidelines and projects in the field of allergic rhinitis. This initiative is currently focused on providing patient-centred guidelines that contribute to an integrated care pathway between the various levels of care and take advantage of digital solutions, and the introduction of integrated care pathways in clinical practice has been recommended. In this article we describe the adaptation for Portugal of the ARIA Integrated Care Pathways document. After a brief review of the epidemiology and impact of allergic rhinitis in Portugal and the activities carried out in Portugal within the ARIA initiative, we describe the broad knowledge base used for the development of recommendations for the pharmacological treatment of allergic rhinitis, and these recommendations are based on the GRADE methodology, real world evidence acquired by mobile technology (mHealth) and resulting from allergenic exposure chamber studies. What follows is a summary of integrated care pathways for allergen immunotherapy produced in 2019. Allergen immunotherapy is considered an example of precision medicine where the use of mHealth technologies will improve stratification for patient selection and response monitoring. These recommendations were considered as best practices of integrated patient-centred care supported by digital systems from Directorate General for Health and Food Safety of the European Union (DG Santé) and represent the ARIA Phase4 Change Management strategy. |
id |
RCAP_85988a67ad8326313c18ff4bd2f5c6dd |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/13777 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in PortugalARIA 2019: Um Percurso Assistencial Integrado para a Rinite Alérgica em PortugalAsthmaClinical Practice GuidelineDelivery of Health CareIntegratedPortugalRhinitisAllergicAsmaGuia de Prática ClínicaPortugalPrestação Integrada de Cuidados de SaúdeRinite AlérgicaThe Allergic Rhinitis and Its Impact on Asthma (ARIA) initiative started more than 20 years ago and has developed and disseminated evidence-based guidelines and projects in the field of allergic rhinitis. This initiative is currently focused on providing patient-centred guidelines that contribute to an integrated care pathway between the various levels of care and take advantage of digital solutions, and the introduction of integrated care pathways in clinical practice has been recommended. In this article we describe the adaptation for Portugal of the ARIA Integrated Care Pathways document. After a brief review of the epidemiology and impact of allergic rhinitis in Portugal and the activities carried out in Portugal within the ARIA initiative, we describe the broad knowledge base used for the development of recommendations for the pharmacological treatment of allergic rhinitis, and these recommendations are based on the GRADE methodology, real world evidence acquired by mobile technology (mHealth) and resulting from allergenic exposure chamber studies. What follows is a summary of integrated care pathways for allergen immunotherapy produced in 2019. Allergen immunotherapy is considered an example of precision medicine where the use of mHealth technologies will improve stratification for patient selection and response monitoring. These recommendations were considered as best practices of integrated patient-centred care supported by digital systems from Directorate General for Health and Food Safety of the European Union (DG Santé) and represent the ARIA Phase4 Change Management strategy.A iniciativa Allergic Rhinitis and Its Impact on Asthma (ARIA) teve início há mais de 20 anos e tem elaborado e disseminado orientações baseadas em evidência, e desenvolvido projetos na área da rinite alérgica. Esta iniciativa está atualmente focada em proporcionar orientações centradas no doente que contribuam para um percurso integrado entre os vários níveis de cuidados e que tirem partido de soluções digitais, tendo sido recomendada a introdução na prática clínica de percursos assistenciais integrados. Neste artigo descrevemos a adaptação para Portugal do documento ARIA Integrated Care Pathways. Após breve revisão sobre a epidemiologia e o impacto da rinite alérgica em Portugal e das atividades realizadas em Portugal no âmbito da iniciativa ARIA, é descrito o conjunto alargado de conhecimento utilizado para o desenvolvimento das recomendações para o tratamento farmacológico da rinite alérgica, recomendações essas baseadas na metodologia GRADE, evidência do mundo real adquirida por tecnologia móvel (mHealth) e resultante de estudos de câmara de exposição alergénica. Em seguida, são resumidos os percursos assistenciais integrados para imunoterapia com alergénios produzidas em 2019. Considera-se a imunoterapia com alergénios um exemplo de medicina de precisão e em que a utilização de tecnologias mHealth permitirá melhorar a estratificação para seleção dos doentes e monitorização da resposta. Estas recomendações foram consideradas como ‘boas práticas’ dos cuidados integrados centrados no doente apoiados por sistemas digitais da DG Santé (Direção Geral de Saúde e de Segurança Alimentar da União Europeia) e representam a estratégia de gestão da mudança da fase 4 do ARIA.Ordem dos Médicos2021-02-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfimage/pngapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documenthttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777oai:ojs.www.actamedicaportuguesa.com:article/13777Acta Médica Portuguesa; Vol. 34 No. 2 (2021): February; 144-157Acta Médica Portuguesa; Vol. 34 N.º 2 (2021): Fevereiro; 144-1571646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/6215https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12428https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12429https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12430https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12431https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12898https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12957Direitos de Autor (c) 2020 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessFonseca, JoãoTaveira-Gomes, TiagoPereira, Ana MargaridaBranco-Ferreira, ManuelCarreiro-Martins, PedroAlves-Correia, MagnaCorreia de Sousa, JaimeCosta, ElísioLourenço, OlgaMorais-Almeida, MárioMorête, AnaRegateiro, FredericoTodo Bom, AnaBachert, ClausPfaar, OliverWallace, DanaBedbrook, AnnaCzarlewski, WienczyslawaBousquet, Jean2022-12-20T11:07:00Zoai:ojs.www.actamedicaportuguesa.com:article/13777Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:23.787206Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal ARIA 2019: Um Percurso Assistencial Integrado para a Rinite Alérgica em Portugal |
title |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal |
spellingShingle |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal Fonseca, João Asthma Clinical Practice Guideline Delivery of Health Care Integrated Portugal Rhinitis Allergic Asma Guia de Prática Clínica Portugal Prestação Integrada de Cuidados de Saúde Rinite Alérgica |
title_short |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal |
title_full |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal |
title_fullStr |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal |
title_full_unstemmed |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal |
title_sort |
ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal |
author |
Fonseca, João |
author_facet |
Fonseca, João Taveira-Gomes, Tiago Pereira, Ana Margarida Branco-Ferreira, Manuel Carreiro-Martins, Pedro Alves-Correia, Magna Correia de Sousa, Jaime Costa, Elísio Lourenço, Olga Morais-Almeida, Mário Morête, Ana Regateiro, Frederico Todo Bom, Ana Bachert, Claus Pfaar, Oliver Wallace, Dana Bedbrook, Anna Czarlewski, Wienczyslawa Bousquet, Jean |
author_role |
author |
author2 |
Taveira-Gomes, Tiago Pereira, Ana Margarida Branco-Ferreira, Manuel Carreiro-Martins, Pedro Alves-Correia, Magna Correia de Sousa, Jaime Costa, Elísio Lourenço, Olga Morais-Almeida, Mário Morête, Ana Regateiro, Frederico Todo Bom, Ana Bachert, Claus Pfaar, Oliver Wallace, Dana Bedbrook, Anna Czarlewski, Wienczyslawa Bousquet, Jean |
author2_role |
author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Fonseca, João Taveira-Gomes, Tiago Pereira, Ana Margarida Branco-Ferreira, Manuel Carreiro-Martins, Pedro Alves-Correia, Magna Correia de Sousa, Jaime Costa, Elísio Lourenço, Olga Morais-Almeida, Mário Morête, Ana Regateiro, Frederico Todo Bom, Ana Bachert, Claus Pfaar, Oliver Wallace, Dana Bedbrook, Anna Czarlewski, Wienczyslawa Bousquet, Jean |
dc.subject.por.fl_str_mv |
Asthma Clinical Practice Guideline Delivery of Health Care Integrated Portugal Rhinitis Allergic Asma Guia de Prática Clínica Portugal Prestação Integrada de Cuidados de Saúde Rinite Alérgica |
topic |
Asthma Clinical Practice Guideline Delivery of Health Care Integrated Portugal Rhinitis Allergic Asma Guia de Prática Clínica Portugal Prestação Integrada de Cuidados de Saúde Rinite Alérgica |
description |
The Allergic Rhinitis and Its Impact on Asthma (ARIA) initiative started more than 20 years ago and has developed and disseminated evidence-based guidelines and projects in the field of allergic rhinitis. This initiative is currently focused on providing patient-centred guidelines that contribute to an integrated care pathway between the various levels of care and take advantage of digital solutions, and the introduction of integrated care pathways in clinical practice has been recommended. In this article we describe the adaptation for Portugal of the ARIA Integrated Care Pathways document. After a brief review of the epidemiology and impact of allergic rhinitis in Portugal and the activities carried out in Portugal within the ARIA initiative, we describe the broad knowledge base used for the development of recommendations for the pharmacological treatment of allergic rhinitis, and these recommendations are based on the GRADE methodology, real world evidence acquired by mobile technology (mHealth) and resulting from allergenic exposure chamber studies. What follows is a summary of integrated care pathways for allergen immunotherapy produced in 2019. Allergen immunotherapy is considered an example of precision medicine where the use of mHealth technologies will improve stratification for patient selection and response monitoring. These recommendations were considered as best practices of integrated patient-centred care supported by digital systems from Directorate General for Health and Food Safety of the European Union (DG Santé) and represent the ARIA Phase4 Change Management strategy. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777 oai:ojs.www.actamedicaportuguesa.com:article/13777 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/13777 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/6215 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12428 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12429 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12430 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12431 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12898 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13777/12957 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2020 Acta Médica Portuguesa info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2020 Acta Médica Portuguesa |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf image/png application/pdf application/pdf application/pdf application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 34 No. 2 (2021): February; 144-157 Acta Médica Portuguesa; Vol. 34 N.º 2 (2021): Fevereiro; 144-157 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130652608561152 |